Dr. Birx now warns Americans NOT to go to the grocery store or pharmacy unless it’s essential during the next 14 days

Dr. Birx now warns Americans NOT to go to the grocery store or pharmacy unless it’s essential during the next 14 days

https://www.dailymail.co.uk/news/article-8188525/Top-White-House-health-official-warns-Americans-NOT-grocery-store-not-essential.html

  • Dr. Deborah Birx, coordinator of the White House coronavirus task force, said the next two weeks are essential to breaking through the outbreak
  • Residents in Pennsylvania, Colorado and Washington, D.C. in particular are told that they must stay in place to prevent the outbreak from worsening
  • She warned even grocery stores and pharmacies must be avoided if possible 
  • Dr. Birx said that hotspots may hit their peak in the next six to seven days
  • New York, Louisiana, and Detroit are hoped to be reaching the peak of their curve
  • Models predict there may be over 850 daily deaths in New York before then
  • The national model predicts the peak in daily deaths in 12 days

A top White House health official has warned to avoid going to the grocery store or the pharmacy unless it is essential for the next two weeks to prevent further spread of coronavirus

The advice was directed mainly at residents of Pennsylvania, Colorado and Washington, D.C. who are still only on the upside of the outbreak curve, meaning it is essential that people remain at home and practice social distancing now to lessen the virus’ impact.

Dr. Deborah Birx, coordinator of the White House coronavirus task force, revealed during Saturday’s press briefing that hotspots of New York, Detroit and Louisiana are predicted to reach the peak of their death tolls in the next six to seven days but that there are other areas of concern emerging around the country. 

The data shows that the daily death toll in New York City could reach as high as 855 people before it is predicted to subside in a week’s time. 

It came as national deaths reached record highs on Saturday rising by 1,497 to a total of 8,503. 

Scroll down for video 

Dr. Deborah Birx, White House Coronavirus Response Coordinator, speaks at the coronavirus briefing at the White House on Saturday. She warned that the next two weeks are the crucial times to practice social distancing and remain inside, even avoiding the grocery store

Dr. Deborah Birx, White House Coronavirus Response Coordinator, speaks at the coronavirus briefing at the White House on Saturday. She warned that the next two weeks are the crucial times to practice social distancing and remain inside, even avoiding the grocery store

According to the model from The Institute for Health Metrics and Evaluation, if the country continues on track with social distancing and lockdowns as it is, the country will reach the peak of its daily deaths from the outbreak in 12 days, on April 16, when 2,644 are predicted

 

According to the model from The Institute for Health Metrics and Evaluation, if the country continues on track with social distancing and lockdowns as it is, the country will reach the peak of its daily deaths from the outbreak in 12 days, on April 16, when 2,644 are predicted

With the current measures in place, the models predict that there will be a total of 93,531 deaths nationally but that social distancing guidelines will see the daily death totals level off

With the current measures in place, the models predict that there will be a total of 93,531 deaths nationally but that social distancing guidelines will see the daily death totals level off 

Video playing bottom right…

Click here to expand to full page

 ‘The next two weeks are extraordinarily important,’ said Birx. 

‘This is the moment to not be going to the grocery store, not going to the pharmacy, but doing everything you can to keep your family and your friends safe and that means everybody doing the six-feet distancing, washing their hands.’

Birx’ comments came after Trump warned America to brace itself for a ‘lot of deaths’ in the coming week, adding that it will be a ‘very horrendous’ time for the nation, as US virus fatalities top 8,500 with at least 311,632 cases as of Saturday night. 

‘This will probably be the toughest week – between this week and next week,’ Trump told reporters. 

‘There will be a lot of death, unfortunately. But a lot less death than if this wasn’t done,’ he added of the measures taken to prevent the spread of the virus. 

The president was joined Saturday by coronavirus taskforce members including Vice President Mike Pence. 

Dr. Birx and Dr. Anthony Fauci were also on hand, as was Dr. Stephen Hahn of the Food and Drug Administratio

Dr. Deborah Birx, White House coronavirus response coordinator, would not comment on when the worst day would be but suggested the current hotspots should see the maximum number of daily deaths in the next six to seven days is social distancing has worked

Dr. Deborah Birx, White House coronavirus response coordinator, would not comment on when the worst day would be but suggested the current hotspots should see the maximum number of daily deaths in the next six to seven days is social distancing has worked 

Trump let Dr. Birx take the lead when asked by a reporter about when the peak of the country’s outbreak could be expected. 

She was hesitant to put a number of when the hotspots will see the most extreme number of deaths but said that it may be in the next six to seven days. 

The curve toward this peak will see a dramatic number of deaths as those who were infected two weeks ago begin to suffer the worst of the illness.  

‘They are predicting in those three hotspots, all of them hitting together in the next six to seven days,’ she said of New York, Detroit and Louisiana.

She also noted that Pennsylvania, Colorado and Washington, D.C. are only ‘starting to go on that upside’ of the coronavirus mortality curve as she urged residents there to stay at home if they could, even avoiding grocery stores and pharmacies when possible. 

The grim news came as the death toll reached record heights on Saturday with nearly 1,500 deaths in 24 hours. 

Confirmed cases of COVID-19 in the United States have increased by more than 100,000 in the past three days as the national death toll stretched over 8,500 on Saturday.  

Many states are now frantically attempting to provide ventilators for hospitals most in need as federal emergency workers also try to answer desperate pleas for respirators.

New York City remains the epicenter of the national outbreak where hundreds of people are dying a day. As of Saturday night, 2,624 people have lost their lives there.

Dr. Birx explained that the city may start to see a drop in the number of new daily cases in the next week but that the death rate would lag and continue to grow. 

‘What we’re seeing today is the people who were infected two to three weeks ago,’ she said.

‘If social distancing and other mitigation efforts worked in New York, and we believe it is working, the cases are going to start to go down, but the mortality will be a lag behind that.’ 

According to predictions highlighted by the White House coronavirus task force, the U.S. can expect to hit the peak of its deaths per day on April 16, 12 days from now, when there will be a predicted 2,644 new deaths reported nationwide. 

If the model tracked by the task force is correct, the curve across the country will then start to move downward with less deaths per day. 

There are a total of 93,531 deaths predicted. according to this model.  

The data for the models was collected by Dr. Christopher Murray and researchers from The Institute for Health Metrics and Evaluation (IHME), an independent population health research center at UW Medicine which is part of the University of Washington. 

Dr. Birx has in recent days guided questions about what can be expected toward the site established by the institute.  

The peak in national deaths per day could see 2,644 new deaths on April 16, based on current data, but daily deaths will then begin to fall as the effects of social distancing are felt

The peak in national deaths per day could see 2,644 new deaths on April 16, based on current data, but daily deaths will then begin to fall as the effects of social distancing are felt 

New York, Louisiana and Michigan are all expected to reach their peak before April 16. 

The data shows that New York is six days away from its peak, on April 10, when it could suffer 855 deaths a day. 

The model predicts there will be 16,261 total deaths in the city.  

Louisiana is also six days away from its peak when there are 76 deaths a day expected. 

Michigan is predicted to reach its peak in seven days on April 11 when 173 deaths are expected. 

 

New York is predicted to reach its peak in six days when there could be 855 deaths a day. The city is thought to be nearing the top of its outbreak curve if current guidelines stay in place

New York is predicted to reach its peak in six days when there could be 855 deaths a day. The city is thought to be nearing the top of its outbreak curve if current guidelines stay in place

The states Dr. Birx warned about are still only on the upward trajectory and have a longer line to wait until they reach the predicted peak number of deaths. 

Washington D.C. may not reach the peak until April 13 in nine days time.  

Colorado has an expected peak in 14 days on April 18 when the model shows there could be 85 new deaths.

Pennsylvania has an even longer wait with the predictions showing 15 days, April 19, before the state reaches peak deaths. It is thought deaths may reach 79 on that day. 

 

The peak in daily deaths in Colorado is predicted to come after the national peak. It will hit on April 18, according to the current model, and Dr. Birx has encouraged residents there to stay inside to ensure that the spread is limited as it starts to rise up the curve of the outbreak

 

The peak in daily deaths in Colorado is predicted to come after the national peak. It will hit on April 18, according to the current model, and Dr. Birx has encouraged residents there to stay inside to ensure that the spread is limited as it starts to rise up the curve of the outbreak 

The District of Columbia may reach the peak of its daily deaths in nine days time if social distancing guidelines continue to be maintained and the current spread is limited

 

The District of Columbia may reach the peak of its daily deaths in nine days time if social distancing guidelines continue to be maintained and the current spread is limited

Pennsylvania could experience almost 80 deaths a day at its peak of the coronavirus outbreak but Dr. Birx warned that people must continue to social distance to not extend this further

 

Pennsylvania could experience almost 80 deaths a day at its peak of the coronavirus outbreak but Dr. Birx warned that people must continue to social distance to not extend this further

Nearly 1.3 million coronavirus tests have been conducted with one-fifth coming back positive, according to new data.

Across state and local laboratories, 1,290,619 tests for the virus, have been run, according to The COIVD Tracking Project.

And while the majority of swabs have come back negative, at least 270,000 people – including 33,000 who have been hospitalized – been confirmed to have the virus. 

However, with health experts say that with millions across the US still awaiting tests, the number of tests that have been performed are far from adequate. 

Dr Birx says they 50 percent of the data for tests that have been conducted.

On Thursday, Birx said that all tests were required to be report their results to the Centers for Disease Control and Prevention (CDC) under the $2 trillion economic stimulus measure signed into law by President Donald Trump.

‘Well, I’m telling you, I’m still missing 50 percent of the data from reporting,’ she told reporters. 

‘I have 660 [thousand] tests reported in. We’ve done 1.3 million…So, we do need to see – the bill said you need to report. We are still not receiving 100 percent of the tests.’

Could “opiated related deaths be on a decline” ?

CDC Tells Hospitals To List COVID as Cause of Death Even if You’re Just Assuming or It Only Contributed

https://www.westernjournal.com/cdc-tells-hospitals-list-covid-cause-death-even-just-assuming-contributed/

The problem with making informed decisions about coronavirus is that we don’t have a whole lot of data on it at the moment.

The data that we do have, meanwhile, could end up being terminally skewed, particularly the data that’s been coming out of China.

The Centers for Disease Control and Prevention’s guidance on determining COVID-19 as a cause of death isn’t going to help those numbers.

Issued March 24, the guidance tells hospitals to list COVID-19 as a cause of death regardless of whether or not there’s actual testing to confirm that’s the case.

Instead, even if the coronavirus was just a contributing factor or if it’s “assumed to have caused or contributed to death,” it can be listed as the primary cause.

The International Statistical Classification of Diseases and Related Health Problems, or ICD, has established the code U07.1 for death by coronavirus infection. There’s a secondary code, U07.2, “for clinical or epidemiological diagnosis of COVID-19 where a laboratory confirmation is inconclusive or not available,” according to the CDC guidance.

“Because laboratory test results are not typically reported on death certificates in the U.S., NCHS is not planning to implement U07.2 for mortality statistics.”

Therein lies the problem.

“The underlying cause depends upon what and where conditions are reported on the death certificate. However, the rules for coding and selection of the underlying cause of death are expected to result in COVID- 19 being the underlying cause more often than not,” the guidelines read.

“COVID-19 should be reported on the death certificate for all decedents where the disease caused or is assumed to have caused or contributed to death. Certifiers should include as much detail as possible based on their knowledge of the case, medical records, laboratory testing, etc.,” the guidance continued.

“If the decedent had other chronic conditions such as COPD or asthma that may have also contributed, these conditions can be reported in Part II.”

Author and former New York Times reporter Alex Berenson, one of the few well-known figures to question some of the statistics on COVID-19, questioned the new CDC guidelines as well:

Earlier this week, President Donald Trump and members of his coronavirus task force announced that they were expecting a death toll of between 100,000 and 240,000 from coronavirus.

In an article on Friday, The Washington Post said some experts didn’t think the White House’s prediction models were accurate. It wasn’t because those experts thought that figure was too high or too low: It’s just because they didn’t think there was enough data to determine a death range yet.

“We don’t have a sense of what’s going on in the here and now, and we don’t know what people will do in the future,” Jeffrey Shaman, a Columbia University epidemiologist whose work was used by the White House to determine the death ranges, said.

“We don’t know if the virus is seasonal, as well.”

It doesn’t help that data when the guidelines for determining who’s actually died of the coronavirus are profoundly vague.

For instance, what happens when an elderly person with numerous underlying conditions comes into the hospital and dies?

What happens when someone suffering from late-stage cancer or liver failure dies in the hospital? If that person was in the final stages of life and no testing is done and no autopsy conducted, what are we to assume?

If no testing is done and a patient’s symptoms are close enough to the seasonal flu, will that person’s death automatically be attributed to COVID-19? And how much of a difference would that make in the numbers, if any?

The Western Journal has emailed the CDC for comment, but did not hear back in time for publication of this article.

There’s no doubt that this guidance will inflate the numbers, the only question is how drastically.

In places like New York City, where medical professionals are painfully overstretched, anyone who dies with an infection that’s vaguely COVID-19-like could potentially have COVID-19 listed as their cause of death.

Consider, for instance, that the CDC is estimating there were between 24,000 and 63,000 deaths in the United States from influenza between October and March.

In NYC, does that mean some of those deaths got lumped under COVID-19? Will this keep on happening?

If so, that could skew the data in a significantly different direction — and it could influence the government’s intervention to stop the spread of the virus.

This is a haphazard way to gather data at a time when that data needs to be more accurate than ever. We can and should do better than this.

 

 

COVID-19 projections assuming full social distancing through May 2020

COVID-19 projections assuming full social distancing through May 2020

As the pandemic progresses, we are working to incorporate new data about the virus in the US.
Please check back on Saturday, April 4 for our next update.

https://covid19.healthdata.org/projections

Use the above hyperlink to find out the projected COVID-19 impact – in days – in your particular state

 

Kentucky: DEA has relaxed controlled substance laws… BUT…we are business as usual

Please contact the Drug Enforcement and Professional Practices Branch of the Kentucky Office of Inspector General in the Cabinet for Health and Family Services at 502-564-7985 with any questions.

APPLICABLE KENTUCKY CONTROLLED SUBSTANCES LAWS

This information is current as of April 2, 2020.

Although the DEA has relaxed Federal controlled substances laws, Kentucky Drug Enforcement and Professional Practices Branch of the Kentucky Office of Inspector General in the Cabinet for Health and Family Services has not. Therefore, Kentucky laws, since they are more stringent, must be followed. Please reference the attached document for additional guidelines.

So the attorneys within the “Cabinet for Health and Family Services ”  have decided that they are not going to made a temporary relaxing of KY’s laws concerning Controlled Substance Acts… to sync with those the DEA has done at the Federal level.

It isn’t as if KY has made so much progress in fighting the war on drugs over the last 50 yrs that relaxing some portions of their Controlled Substance Act would cause them to loose so much grown in fighting the war on drugs in their state.

Of course, this decision appears to have been made by those who are part of our judicial system and may not take into consideration for the health of anyone that has a valid medical necessity for being prescribed controlled substances.

There was nothing mentioned in the information that I have received that there appears to also no change in how those being treated for  substance abuse/addicts… if so, at least they are consistent… consistently STUPID !

APPLICABLE KENTUCKY CONTROLLED SUBSTANCES LAWS 4.2.2020 V 1

As full disclosure, I have been a licensed Pharmacist in the State of KY since July 1970

Headlines suggests increased controlled substance production quotas – details suggests oral opiates – business as usual.

Exclusive: Opioid supply crunch for U.S. coronavirus patients prompts appeal to relax limits

https://www.reuters.com/article/us-health-coronavirus-usa-opioids-exclus-idUSKBN21K2ZJ

(Reuters) – U.S. doctors running out of narcotics needed for COVID-19 patients on ventilators are asking the federal government to raise production limits for drugmakers, according to a letter seen by Reuters, after national quotas had been tightened to address the opioid addiction crisis.

Health workers in protective gear peer from a tent which was constructed to test people for the coronavirus disease (COVID-19) outside the Brooklyn Hospital Center in Brooklyn, New York City, U.S., March 27, 2020. REUTERS/Andrew Kelly – RC2ESF9VPJJ5

The global coronavirus pandemic has led to more than 5,300 deaths nationwide, with over 227,000 confirmed cases, according to a Reuters tally, and has sent states and the federal government scrambling to obtain enough ventilators to treat patients struggling to get oxygen.

At the same time, hospitals are churning through drugs, including injectable fentanyl, used to safely place patients on ventilators and keep them sedated so their lungs can heal.

The U.S. government sets annual limits on how much tightly regulated narcotics can be produced by pharmaceutical companies, and then allocates portions to various manufacturers. Amid an outcry over opioid abuse, the U.S. Drug Enforcement Administration (DEA) reduced the overall fentanyl quota by over 30% for 2020. 

In a letter to the DEA on Tuesday, groups including the American Medical Association and the American Society of Health-System Pharmacists (ASHP) said supplies of injectable fentanyl, morphine and hydromorphone are already in short supply and asked for increased company allocations. 

“We appreciate DEA’s work to protect against diversion and maintain control over the flow of opioids into our communities,” they wrote. “However, during this unprecedented health crisis, hospitals must have sufficient (drug) supply to treat patients.”

A senior DEA official told Reuters the agency currently believes the existing national quotas are “completely sufficient” to meet the spike in demand,

and there is still room for additional allocations to companies under the cap to make millions more injectable doses that hospitals use.

The agency is closely monitoring the situation, however, and has begun discussing steps it can take to expedite an overall quota hike if necessary, the official, who asked to remain anonymous, said.

“These are unprecedented times, and the DEA is taking unprecedented actions to make sure we support hospitals on the front lines,” the official said.

In a statement, Pfizer Inc (PFE.N) said it adjusted production schedules to prioritize injectable fentanyl in high demand. The DEA raised the company’s quota this week, it said.

U.S. hospitals are currently projected to need about 40,000 intensive care beds to treat patients with COVID-19, the highly contagious respiratory illness caused by the virus, according to the Institute for Health Metrics and Evaluation at the University of Washington. That could lead to a shortage of nearly 20,000, IHME said.

Nearly 32,000 ventilators may be needed, IHME said, although Governor Andrew Cuomo has said New York alone may need 30,000 to address the expected spike in cases in coming days and weeks at the outbreak’s current epicenter.

Doctors and nurses can use a range of drugs to help patients that need a ventilator. Some, such as anesthesia drug propofol, are not as tightly regulated as opioids like fentanyl. But hospital staff around the country have already begun reporting shortages of many of these drugs, and difficulty filling orders.

Demand for fentanyl, hydromorphone and morphine spiked 67% in March compared to January, according to Vizient, which helps healthcare providers manage their supply chains. At the same time, the fill rate for Vizient members had dropped to 73% by March 25.

‘A VERY SERIOUS ISSUE’

Dr. Michael Ganio, director of pharmacy practice and quality at ASHP, said doctors will be forced to use different and less common combinations of sedatives if shortages continue to mount. That increases the risk of medical errors, he said.

The DEA last week agreed to relax inventory controls for manufacturers, allowing them to produce and store more than 65% of their annual quota throughout the duration of the emergency.

“This exception does not authorize any manufacturer to exceed his previously established annual manufacturing quota,” the DEA wrote.

The U.S. Department of Health and Human Services issued a request for information from drug manufacturers this week on their ability to rapidly produce the maximum number of ventilator medicines, with various quantity and price scenarios.

“The United States has a critical need to procure priority medicines for ventilated ICU (intensive care unit) patients in response to COVID-19,” it said.

Patients may receive paralyzing drugs, in addition to sedatives, to increase the ventilator’s effectiveness. If the sedatives are not effective, a patient could potentially gain consciousness but be unable to alert medical staff.

“It keeps me up at night,” Ganio said. “This is a very serious issue we’re seeing.”

If you read this article… everything that is being discussed is INJECTABLES POTENTIALLY having a INCREASE in INJECTABLE PRODUCTION QUOTAS. According to the article, NOTHING is being discussed about oral opiates.

And according to this UNNAMED DEA OFFICIAL…. supplies a of injectable controlled substances are COMPLETELY SUFFICIENT !!!

A senior DEA official told Reuters the agency currently believes the existing national quotas are “completely sufficient” to meet the spike in demand

30-45 days ago, there were a handful of words that was not in the vocabulary of the “average joe/jane”… COVID-19, Plaquenil (Hydroxychloroquine), Chloroquine, Ventilator, shelter in place for starters.

Many of us suspected that it would take some sort of catastrophe affected the average  joe/jane to maybe get some change to the way that the war on drugs/pts was being conducted.  Who could have predicted that the catastrophe would only potentially affect a very narrow list of controlled substances ?

How many deaths from complication of a pt’s existing comorbidity issues will be blamed on COVID-19 or if they have a legally prescribed opiate in their toxicology be labeled as a opiate related death and is there going to be a increase in suicides because of shortage of opiates that the DEA will not admit that it exists or take any prompt action to attempt to increase availability of controlled substances – ACROSS THE LINE OF PRODUCTS.

Most all opiate related DEAths …. have a common denominator !!!

 

 

RIP Jennifer Hill – CRPS Warrior SUICIDE

 

RIP Gravestone

Committed Suicide on her 53rd BIRTHDAY April 1, 2020

my money is on that no one involved in her pain management care – or denial of care – will be held responsible for this

Independent pharmacies are working around the clock to ensure patients receive the medications they need during the pandemic

National Community Pharmacists Association CEO Doug Hoey says pharmacies are working around the clock to ensure patients receive the medications they need during the pandemic.

https://video.foxbusiness.com/v/6146117001001/?playlist_id=933116627001#sp=show-clips

Doctor Shares The Biggest Lie About COVID-19 | UK Data

https://youtu.be/0ts8X3HDtPE

Doctor Shares The Biggest Lie About COVID-19 | UK Data

There has been a particularly harmful misconception which has led many to believe coronavirus is a trivial problem that won’t affect them. These are results from the first 775 patients admitted to intensive care in the UK, with COVID-19. Time to put the misconception that this disease only preys on the elderly and those with significant medical conditions, to rest. Erratum: Thanks to a couple of friends who pointed out that I should’ve been clearer with the deaths statistic – when saying around half have died, that refers to those with outcomes recorded, ie patients who have either left ICU alive or dead. Many of these patients are still in ICU right now, so the rate may change *however* if you click the link below you can see a steady state emerging between discharge alive and dead, suggesting the 52:48 ratio is probably about right. Link to ICNARC report: https://www.icnarc.org/About/Latest-N… Next video is ready to go and is non-COVID, promise! ETA: soon.

CDC has lied about the need to wear a mask in public

chain pharmacies failed in lawsuit blaming physicians being responsible for the opiate crisis.

Judge Dismisses Pharmacies’ Lawsuit Against Physicians

https://www.nytimes.com/aponline/2020/04/01/business/bc-us-opioid-crisis-lawsuits.html

CLEVELAND —

A federal judge in Cleveland has dismissed an effort by pharmacy companies to shift their liability for the opioid crisis to physicians and practitioners in the two Ohio counties suing them, alleging they created a public nuisance.

U.S. District Judge Dan Polster ruled Tuesday that lawsuits filed by Cuyahoga County, which includes Cleveland, and Summit County, which includes Akron, are not tied to prescribing practices, but to the failure of the companies to implement systems and policies to prevent the illegal diversion of painkillers.

“Plaintiffs’ theory and intended proof do not rely on whether prescribers made negligent or fraudulent representations,” Polster wrote.

Adding claims against prescribers would cause a significant delay in the trial of the counties’ lawsuits by defense lawyers practicing the Seattle area against Walgreens, CVS, Rite Aid, Discount Drug Mart and HBC, scheduled to begin in November, Polster said.

The two counties reached a $250 million settlement with three drug distributors and a generic drug manufacturer before the start of a trial last October.

Attorneys for the pharmacy chains argued in a filing in January that Polster should reject the counties’ claims because pharmacies can fill only prescriptions written by prescribers authorized by the state of Ohio and registered with the U.S. Drug Enforcement Administration.

“While pharmacists are highly trained and licensed professionals, they did not attend medical school and are not trained as physicians,” the attorneys wrote.

The executive committee for plaintiff attorneys in the multi-district opioid litigation issued a statement Wednesday applauding Polster’s ruling.

“The dismissal of defendants’ third-party claims reaffirms that pharmacies must be held accountable for years of sidestepping their obligations under the law to protect the American people from controlled substances,” the statement said.

Polster is overseeing more than 2,000 opioid-related lawsuits filed by cities, counties, tribal governments and hospitals against drugmakers, distributors and pharmacies seeking to hold them accountable for the opioid crisis, which has been linked to more than 400,000 deaths in the U.S. since 2000.

Those deaths include fatal overdoses from both prescription opioids and illegal ones such as heroin and illicitly made fentanyl.

Attorneys for the pharmacy chains argued in a filing in January, pharmacists are highly trained and licensed professionals, they did not attend medical school and are not trained as physicians.

The question has to be asked… if the chain pharmacies’ attorney are claiming that pharmacists do not have the educational background of a physician. Why aren’t the chains challenging the DEA in making the interpretation of the Controlled Substance Act .. in particular the phrase “corresponding responsibility” that Pharmacists have the legal responsibility to basically provide a SECOND MEDICAL OPINION on the appropriateness of prescription for a pt.. when the pharmacist – generally – doesn’t have access to the pt’s medical records, have no training nor legal right to do a in person physical exam of the pt and in general we are talking about subjective diseases. Where only the pt really has a idea of the intensity of their health issues and symptoms.

With all the monies that these chains put into political election campaigns and lobbying Congress and instead of trying to help their pts dealing with subjective diseases… they file lawsuits against prescribers who have been trying to help improve the quality of life of those suffering from subjective diseases. Can anyone really even think that these chain pharmacies have the any interest in the quality of life of those pts suffering from subjective diseases by actions such as filing these lawsuits against prescribers ?